Back to the main directory
EarningsReview / Equity
- Q219 results and 15 questions for management by BNP Paribas Exane
- Starting to get traction by BNP Paribas Exane
- Evolution Gaming (Buy, TP: SEK750.00) - >500 tables by end-2018e by DnB Markets
- DAL: Margin Expansion within Reach Despite Fuel Headwinds by Raymond James
- FDC: Compelling Setup Into 3Q18 Print; Reiterate Outperform, $28 TP by Raymond James
- ISTR: Reiterate Market Perform; Expanding into Texas Through Mainland Bank by Raymond James
- Don''t feed the animals by BNP Paribas Exane
- Many strings to the bow by BNP Paribas Exane
- Semi correction - what is priced in? by BNP Paribas Exane
- Loomis (Buy, TP: SEK375.00) - Spanish centre of excellence by DnB Markets
- A pause for breath? by BNP Paribas Exane
- Atea (Sell, TP: NOK111.00) - Rally overdone by DnB Markets
- Seafood - The Fat Trout Weekly by DnB Markets
- Flows slow markedly, but attractive price on asset sale by BNP Paribas Exane
- PNC: 3Q18 Follow-Up: Growth Headwinds Weigh on EPS; Reit. Market Perform by Raymond James
- GILD: 3Q18 Preview: Street May Be Missing the WHAT and the WHY of the HIV Segment by Raymond James
- Flex LNG (Buy, TP: NOK22.30) - Time for discount to close by DnB Markets
- Veoneer (Buy, TP: SEK550.00) - Overtaking cyclical concerns by DnB Markets
- Outokumpu (Hold, TP: EUR5.00) - Weak end to 2018e by DnB Markets
- Too early to play a down cycle by BNP Paribas Exane
- Espresso | Swedbank | Not Rated | Stable quarter expected by Kepler Cheuvreux
- Yes, it''s slow, but look at those fundamentals! by BNP Paribas Exane
- Previewing Q4 - Separation the bigger picture by BNP Paribas Exane
- Espresso | SSAB | Buy | Q3 supported by lower costs and Americas by Kepler Cheuvreux
- Regeneron-ation of Sanofi by BNP Paribas Exane
- Quality franchise but not immune to weaker markets by BNP Paribas Exane
- CBSH: Raising 2018 EPS Estimate (3Q Beat), But Reiterating Underperform by Raymond James
- ETH: Reaffirm Strong Buy & $27 Target; Updated Thoughts on Tariffs by Raymond James
- ADMA: BIVIGAM Launch Pushed Back – Revenues to Begin in 2019; Lowering PT by Raymond James
- 3Q Transport Preview; Expecting Robust Quarter but Eyeing Peak Pricing Optics by Raymond James
- CEO roadshow feedback - Regulation, MandA and ad trends by BNP Paribas Exane
- Who could Kerry acquire? by BNP Paribas Exane
- NV/PLC: what next? by BNP Paribas Exane
- Tryg (Hold, TP: DKK155.00) - Run-offs offset higher large claims by DnB Markets
- Espresso | Edenred | Buy | Q3 revenue preview by Kepler Cheuvreux
- Investment Daily 12/10/2018 by BNP Paribas Exane
- What the SRI investor should have read by BNP Paribas Exane
- Securitas (Buy, TP: SEK180.00) - Seeking European leverage by DnB Markets
- Positive results despite a more volatile EM backdrop by BNP Paribas Exane
- WFC: Reducing EPS Estimates for Smaller Balance Sheet by Raymond James
- Weekly NAV update by DnB Markets
- Veoneer (Buy, TP: SEK550.00) - Overtaking cyclical concerns by DnB Markets
- DNO (Buy, TP: NOK20.00) - Powering ahead with positive news by DnB Markets
- SSAB (Hold, TP: SEK45.00) - Strong US plate now priced in by DnB Markets
- Good news, too loudly applauded by BNP Paribas Exane
- Espresso | MRG | Buy | Strong growth to continue in Q3 and profitability to improve by Kepler Cheuvreux
- Undervalued defensive qualities and headwinds abating by BNP Paribas Exane
- Exploration and Production: 3Q18 Earnings Preview by Raymond James
- Restaurants: Expect Strong 3Q EPS, Investor Focus on QTD/Outlook; Top Ideas DIN, BLMN, PLAY by Raymond James
- Danone : Rapport de la commission d’enquête sur l’alimentation industrielle : haro sur les produits transformés et ultra-transformés proposés par l’industrie alimentaire (Carrefour, Sodexo, Danone, Bonduelle et Casino) by Oddo BHF